🇺🇸 FDA
Patent

US 8598312

Inhibitors of antigen presentation by MHC class II molecules

granted A61KA61K38/00A61P

Quick answer

US patent 8598312 (Inhibitors of antigen presentation by MHC class II molecules) held by Provid Pharmaceuticals Inc. expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provid Pharmaceuticals Inc.
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P19/02, A61P25/00